American Heart Association (AHA)

The American Heart Association (AHA) funds cardiovascular medical research, educates consumers on healthy living and fosters appropriate cardiac care in an effort to reduce disability and deaths caused by cardiovascular disease and stroke. The AHA also is a key resource for the latest cardiology science through its journals and annual meeting.

New AI program delivers rapid, accurate echo video assessments
The new technology shows early potential to make a significant impact on imaging workflows and patient care.
Genetic predisposition to depression increases CVD risk in women, but not men
The heightened risks were even seen in women who were never diagnosed with a psychiatric disorder. It remains unclear why the same trend was not seen in men.
ATTR-CM drug acoramidis, now approved by the FDA, linked to positive long-term data
Cardiovascular Business spoke with cardiologist Daniel Judge, MD, about the long-term benefits of acoramidis, a new drug therapy that just received FDA approval to treat transthyretin amyloid cardiomyopathy.
Martha Gulati highlights 'exciting' progress in preventive cardiology
Martha Gulati, MD, spoke to Cardiovascular Business at AHA Scientific Sessions 2024 about key developments in obesity treatment and CVD prevention.
LAAC with Watchman FLX reduces bleeding risks after AFib ablation
The new data, presented during AHA Scientific Sessions 2024, suggest LAAC with Boston Scientific's Watchman FLX could be a safe, effective alternative to OAC for limiting post-ablation strokes.

New ACC/AHA guidelines detail updated recommendations for PCI, CABG

The new guidelines emphasize the importance of equal access to care among all patient populations, regardless of race or gender.

December 10, 2021

American Heart Association supports new ‘surprise billing’ legislation, but physician groups have serious doubts

According to the AHA, the No Surprises Act will "make a truly meaningful difference" to millions of patients. Physicians, on the other hand, have shared significant concerns about the legislation.

December 7, 2021

As Omicron variant spreads, American Heart Association highlights continued support of COVID-19 vaccination

The organization also urged all eligible adults to seek out a booster shot.

December 6, 2021

Stem cell therapy for heart failure lowers risk of adverse outcomes

“Cell therapy has the potential to change how we treat heart failure,” one researcher said.

November 16, 2021

Cardiologs puts its AI model up against the Apple Watch—and wins

The company reported that its deep neural network led to improved sensitivity and fewer unclassified findings.

November 16, 2021

High-dose icosapent ethyl treatment makes minimal impact on non-hospitalized COVID-19 patients

The analysis, presented at AHA Scientific Sessions 2021, included approximately 2,000 symptomatic COVID-19 patients who were not necessarily sick enough to be hospitalized.

November 16, 2021